Key result
Perceval S sutureless valve predicted to reduce complications and save ~€3,600 vs traditional valves.
Why the study?
The economic impact of using the Perceval S sutureless valve compared to traditional valves in isolated or concomitant AVR procedures was not well defined across multiple European countries.
Does the Perceval S sutureless valve reduce hospital costs and complications compared to traditional valves in patients undergoing AVR?
Does the Perceval S sutureless valve reduce hospital costs and complications compared to traditional valves in patients undergoing AVR?
An economic model suggests that the higher acquisition cost of the Perceval S sutureless valve is offset by savings in surgery and hospital stay costs compared to traditional valves.
Answers are grounded in this paper and cite their sources.
May expand operable elderly patients via sutureless AVR; leaves open need for randomized outcome confirmation.
BACKGROUND: aortic valve replacement (AVR) the most common heart valve operation, accounts for a majority of all valve surgery performed in the elderly. The Perceval S (P) is a new aortic valve which is implanted without suturing, which causes a significant reduction in cross-clamping times (CCTs), and makes valve implantation easier and faster thanks to its collapsed profile. These features potentially allow the pool of operable patients to be expanded, even with minimally invasive surgery in isolated AVRs. AIM: to predict costs and outcomes of AVR procedures associated with this new valve in 4 European countries (Italy, France, Germany, and UK), as compared to traditional (T) valve implants, from the cost perspective of the hospital. METHOD: a probabilistic, patient-level simulation model was fully coded in WinBugs, permitting a seamless integration of parameter estimation and outcomes prediction, which was entirely based on the associated CCTs and on the surgical technique (mini-invasive [MiS] vs. full sternotomy [FS]), through published correlations. Unit cost were retrieved from official and literature sources for all countries. Besides the incorporated probabilistic sensitivity analysis, a series of deterministic sensitivity analyses was performed. RESULTS: the model predicts the use of the Perceval S valve to be associated with less complications and with savings (valve cost excluded), mainly related to a reduction in surgery costs and ICU/hospital bed days. These savings range from € 3,600 (Italy) to £ 3,900 (UK) for PFS in isolated AVRs and from about € 6,000 (Italy) to £ 6,700 (UK) for PMiS in isolated AVRs, and for PFS in concomitants. Extensive sensitivity analyses confirm the robustness of such findings.CONCLUSIONS: the results of the present analysis indicate that the hospital acquisition cost difference between the new sutureless Perceval S valve and traditional valves is offset by important savings in other cost items.
No takes yet. Share an insight, caveat, or question.
Pradelli et al. (2012) studied Aortic valve replacement (AVR). Perceval S sutureless valve vs. Traditional valve implants was evaluated on Costs and outcomes (complications, surgery costs, ICU/hospital bed days). The Perceval S sutureless valve is predicted to reduce complications and generate savings (excluding valve cost) ranging from €3,600 to £6,700 per procedure compared to traditional valves.
Synapse has enriched 10 related papers. Consider them for comparative context: